The WHO's critical bacteria list: scientific response eight years after its implementation and development of an AI-based tool for its monitoring

世界卫生组织关键细菌名单:实施八年后的科学回应及基于人工智能的监测工具的开发

阅读:1

Abstract

BACKGROUND: In 2017, the World Health Organization (WHO) issued a global alert identifying 12 bacteria in urgent need of new treatments. MAIN BODY: This study assesses the scientific community's response to this alert by analyzing original research publications using LLMzCor, an AI-based tool developed and validated by our group. To compare trends, we focused on publications from 5 years before and after the alert, specifically on three bacteria listed in the WHO alert, sorted by priority level: Acinetobacter baumannii (Critical), Shigella spp (High), and Neisseria gonorrhoeae (Medium) and three non-listed as controls (Rickettsia spp., C. trachomatis, and C. difficile). Articles were classified into three categories: (i) identification of Resistant strains, (ii) development of New treatments, and (iii) Immunization strategies. RESULTS: Although overall publications increased after the WHO alert, no statistically significant changes were found in the reports of Resistant strains over time. The development of New treatments for the listed bacteria showed a slight increase, between 2% and 10%. Furthermore, Immunization strategies remained relatively unchanged, with less than 2%. Meanwhile, LLMzCor demonstrated robust performance across categories, F1-scores ranging from 0.65 to 0.72 in key classifications, while recall peaked at 0.75, indicating a high capacity to identify relevant articles. These results support the model's reliability for large-scale automated classification of scientific abstracts. CONCLUSION: These findings, supported by LLMzCor, underscore the urgency of a stronger WHO alert and action plans to develop new strategies against bacterial resistance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。